Clinical characteristics and outcome of patients with pandemic 2009 influenza A(H1N1)v virus infection admitted to hospitals with different levels of health-care;Características clínicas y evolución de los pacientes con infección por el virus pandémico influenza A (h1N1)v 2009 ingresados en hospitales con diferentes niveles de atención de salud

Revista Espanola de Quimioterapia

Volumn 25, Issue 1, 2012, Pages 56-64

  Gutiérrez Cuadra, Manuel ^a   González Fernández, José Luis ^a   Rodríguez Cundin, Paz ^b   Fariñas Álvarez, Concepción ^b   Juan, María Victoria San ^c   Parra, José Antonio ^c   Carrascosa, Miguel ^d   Fariñas, María Carmen ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL DE LAREDO   (Spain)

Author keywords

Hospital characteristics; Outcome; Pandemic H1N1 infection

Indexed keywords

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOXEMIA; INFLUENZA VIRUS A H7N7; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYALGIA; OUTCOME ASSESSMENT; PNEUMONIA; PREDICTOR VARIABLE; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; PUBLIC HOSPITAL; RISK; RISK FACTOR; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; COHORT STUDIES; COMORBIDITY; DATA COLLECTION; DISEASE OUTBREAKS; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; OSELTAMIVIR; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RISK FACTORS; SPAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859651401     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sullivan SJ, Jacobson RM, Dowdle WR, Poland GA. 2009 H1N1 influenza. Mayo Clin Proc 2010; 85:64-76.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
3. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680e9.
4. Surveillance Group for New Influenza A (H1N1) Virus Investigation and Control in Spain. New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill. 2009; 14.pii:19209.
5. Viasus D, Paño-Pardo JR, Pachón J, Campins A, López-Medrano F, Villoslada A, et al. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect 2011; 17:738-746.
6. Ain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.N Engl J Med 2009; 361:1935-1944.
7. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009; 374:451-458.
8. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009.Euro Surveill 2009; 20;14(33). pii: 19309.
9. Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010; 182:257-264.
10. Chang YS, van Hal SJ, Spencer PM, Gosbell IB, Collett PW. Comparison of adult patients hospitalised with pandemic (H1N1) 2009 influenza and seasonal influenza during the"PROTECT" phase of the pandemic response. Med J Aust 2010; 192:90-93.
11. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study.BMJ 2009; 339:b5213.
12. Guyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG A, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).Thorax 2010; 65:645-651.
13. Supervía A, Del Baño F, Maldonado G, O. Pallàs, Aguirre A, Vilaplana C, et al. Predictive factors of 2009 H1N1 virus infection in patients with influenza syndrome. Rev Esp Quimioter 2011:24:25-31.
14. World Health Organization. Interim WHO guidance for the surveillance of human infection with swine influenza A (H1N1) virus, 27 April 2009. World Health Organization. Web site: http://www.who.int/csr/disease/swineflu/WHO_case_definitions.pdf. Accessed June 1, 2009.
15. Centers for Disease Control and Prevention (CDC). Interim guidance on case definitions to be used for investigations of novel influenza A (H1N1) cases. Available at URL: http://www.cdc.gov/h1n1flu/casedef.htm
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
17. Miller RR 3rd, Markewitz BA, Rolfs RT, Brown SM, Dascomb KK, Grissom CK, et al. Clinical findings and demographic factors associated with intensive care unit admission in Utah due to 2009 novel influenza A (H1N1) infection. Chest 2010; 137:752-758.
18. Campbell A, Rodin R, Kropp R, Mao Y, Hong Z, Vachon J, et al. Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza. CMAJ 2010; 182:349-355.
19. Centers for Disease Control and Prevention (CDC). Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009. MMWR Morb Mortal Wkly Rep 2010; 58:1436-1440.
20. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-1902.
21. Erkoreka A. The Spanish influenza pandemic in occidental Europe (1918-1920) and victim age. Influenza Other Respi Viruses 2010; 4:81-89.
22. Viasus D, Paño-Pardo JR, Pachón J, Riera M, López-Medrano F, Payeras A, et al. Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes. Medicine (Baltimore) 2011; 90:328-336.
23. Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, Suh J, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010; 134:235-243.
24. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008; 358:261-273.
25. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León M, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis.Lancet 2009; 374:2072-2079.
26. Martín-Loeches I, Sanchez-Corral A, Diaz E, Granada RM, Zaragoza R, Villavicencio C, et al. Community-Acquired Respiratory Co-infection (CARC) in Critically Ill Patients Infected With Pandemic 2009 Influenza A (H1N1) Virus Infection. Chest 2011; 139:555-562
27. Nougairede A, Ninove L, Zandotti C, Thiberville SD, Gazin C, La Scola B, et al. Interim report on A/H1N1 Influenza Virus pandemic in Marseille, France, April-November 2009. Clin Microbiol Infect 2010; 16:322-325.
28. Khandaker G, Dierig A, Rashid H, King C, Heron L, Booy R. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza and Other Respiratory Viruses 2011; 5:148-156.
29. Viasus D, Paño-Pardo JR, Pachón J, Riera M, López-Medrano F, Payeras A, et al. Timing of Oseltamivir Administration and Outcomes in Hospitalized Adults with Pandemic 2009 Influenza A (H1N1) Virus Infection. Chest 2011; 140:1025-1032.
30. Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med 2000; 342:1573-1580.